GoodRx Holdings, Inc. (GDRX) Income Tax Expense (Benefit) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
GoodRx Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2024.
  • GoodRx Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $1.3 M, a 81.1% decline year-over-year.
  • GoodRx Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was -$52.3 M, a 453% decline year-over-year.
  • GoodRx Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was -$46.7 M, a 587% decline from 2022.
  • GoodRx Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was $9.6 M, a 36.3% decline from 2021.
  • GoodRx Holdings, Inc. annual Income Tax Expense (Benefit) for 2021 was $15.1 M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$52.3 M $1.3 M -$5.58 M -81.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$46.7 M $1.23 M +$4.01 M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$50.7 M -$8.11 M -$27.6 M -142% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$23.1 M -$46.7 M -$38 M -434% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $14.8 M $6.89 M +$5.24 M +317% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $9.6 M -$2.77 M -$48.6 M -106% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $58.2 M $19.5 M +$310 K +1.62% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $57.8 M -$8.74 M +$28.6 M +76.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $29.3 M $1.65 M +$14.2 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $15.1 M $45.8 M +$53.1 M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$38.1 M $19.2 M +$37 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$75.1 M -$37.3 M -$45 M -587% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$30.1 M -$12.6 M -$20.3 M -262% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$9.83 M -$7.36 M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$17.9 M -$23.6 M -412% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $7.66 M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $7.77 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 $5.73 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.